The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer. (Q39875256)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

The therapeutic potential of recombinant BCG expressing the antigen S1PT in the intravesical treatment of bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ivan P Nascimento

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ivan P Nascimento

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Luciana Leite

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

Priscila M Andrade

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Daher C Chade

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Fabiola E Villanova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Enrico Andrade

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Miguel Srougi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

publication date

9 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

520-525

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19272796%20AND%20SRC:MED&resulttype=core&format=json

Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Bacille Calmette-Guérin in superficial transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Role of animal models in understanding intravesical therapy with bacille Calmette-Guérin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

T-cell subsets required for intravesical BCG immunotherapy for bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Immunotherapy for bladder cancer using recombinant bacillus Calmette-Guerin DNA vaccines and interleukin-12 DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

A new rapid and simple non-radioactive assay to monitor and determine the proliferation of lymphocytes: an alternative to [3H]thymidine incorporation assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Role of Th1-stimulating cytokines in bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017

Risk factors and clinical outcomes of patients with node-positive muscle-invasive bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2008.12.017